Interventional × Ovarian Neoplasms × sargramostim × Clear all Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers
Phase 1/2 Completed
26 enrolled 14 charts
Vaccine Therapy in Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers
Phase 1 Completed
13 enrolled 11 charts
Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer
Phase 2 Terminated
120 enrolled 12 charts
Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer
Phase 1/2 Completed
51 enrolled
J65
Phase 1 Completed
39 enrolled
PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer
Phase 1/2 Completed
51 enrolled 20 charts
HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer
Phase 1 Completed
60 enrolled
Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Cancer
Phase 1 Completed
p53 Vaccine for Ovarian Cancer
Phase 2 Terminated
21 enrolled
GM-CSF, Sargramostim in Women With Recurrent Ovarian Cancer
Phase 2 Completed
72 enrolled 8 charts
Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or Recurrent
Phase 1 Withdrawn
S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer
Phase 1 Terminated
14 enrolled
Vaccine Therapy in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer
Phase 1 Completed
9 enrolled 7 charts
Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer
Phase 2 Completed
40 enrolled
Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer
Phase 2 Completed
59 enrolled 5 charts
Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors
Phase 2 Completed
20 enrolled